全文获取类型
收费全文 | 31017篇 |
免费 | 2747篇 |
国内免费 | 75篇 |
专业分类
耳鼻咽喉 | 334篇 |
儿科学 | 971篇 |
妇产科学 | 1270篇 |
基础医学 | 3347篇 |
口腔科学 | 593篇 |
临床医学 | 6043篇 |
内科学 | 5364篇 |
皮肤病学 | 657篇 |
神经病学 | 2635篇 |
特种医学 | 880篇 |
外科学 | 4007篇 |
综合类 | 357篇 |
一般理论 | 23篇 |
预防医学 | 3013篇 |
眼科学 | 496篇 |
药学 | 2071篇 |
中国医学 | 24篇 |
肿瘤学 | 1754篇 |
出版年
2023年 | 327篇 |
2022年 | 229篇 |
2021年 | 617篇 |
2020年 | 442篇 |
2019年 | 601篇 |
2018年 | 847篇 |
2017年 | 696篇 |
2016年 | 785篇 |
2015年 | 844篇 |
2014年 | 1172篇 |
2013年 | 1574篇 |
2012年 | 2010篇 |
2011年 | 2095篇 |
2010年 | 1232篇 |
2009年 | 1281篇 |
2008年 | 1967篇 |
2007年 | 1936篇 |
2006年 | 1993篇 |
2005年 | 1954篇 |
2004年 | 1863篇 |
2003年 | 1608篇 |
2002年 | 1493篇 |
2001年 | 381篇 |
2000年 | 313篇 |
1999年 | 416篇 |
1998年 | 434篇 |
1997年 | 358篇 |
1996年 | 321篇 |
1995年 | 303篇 |
1994年 | 252篇 |
1993年 | 219篇 |
1992年 | 220篇 |
1991年 | 227篇 |
1990年 | 224篇 |
1989年 | 187篇 |
1988年 | 186篇 |
1987年 | 165篇 |
1986年 | 146篇 |
1985年 | 162篇 |
1984年 | 162篇 |
1983年 | 143篇 |
1982年 | 137篇 |
1981年 | 149篇 |
1980年 | 120篇 |
1979年 | 107篇 |
1978年 | 110篇 |
1977年 | 73篇 |
1976年 | 65篇 |
1975年 | 72篇 |
1973年 | 75篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
62.
63.
Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair. 总被引:4,自引:0,他引:4
Negin Amanat Michelle McDonald Craig Godfrey Lynne Bilston David Little 《Journal of bone and mineral research》2007,22(6):867-876
We hypothesized that ZA treatment would bolster fracture repair. In a rat model for closed fracture healing, a single dose of ZA at 0, 1, or 2 wk after fracture significantly increased BMC and strength of the healed fracture. Delaying the dose (1 or 2 wk after fracture) displayed superior results compared with dosing at the time of fracture. INTRODUCTION: Bisphosphonates are known to increase bone strength and thus the resistance to fracture by decreasing osteoclastic bone resorption. These properties may enable bisphosphonates to also increase the strength of fracture repair. Zoledronic acid (ZA) is a potent bisphosphonate with a high affinity for bone mineral, allowing bolus intravenous dosing in a range of indications. In this study, we examined the application of bolus dose ZA in endochondral fracture repair. MATERIALS AND METHODS: Carbon-14 labeled ZA was used in a closed rat fracture model. Rats were divided into five treatment groups (n = 25 per group): saline control, local ZA (0.01 mg/kg), and three systemic bolus ZA groups (0.1 mg/kg) with different administration times: at fracture, 1 wk after fracture, and 2 wk after fracture. Rats were killed 6 wk postoperatively. Postmortem analyses included radiography, QCT, microCT, biomechanical testing, scintillation counting, autoradiography, and histology. RESULTS: Single-dose systemic ZA administration significantly increased callus volume, callus BMC, and mechanical strength. Perioperative treatment increased mechanical strength by 30% compared with controls (p < 0.05). Administering the systemic dose at 1 or 2 wk after fracture further increased mechanical strength compared with controls by 44% and 50%, respectively (p < 0.05). No significant differences in mechanical parameters were seen with local injection at the dose studied. Autoradiographic analysis indicated that ZA binds significantly to bone that is present at the time of administration. ZA quantification indicated that delayed administration significantly increased the uptake efficiency in the callus. Histological and microCT analysis showed that ZA treated calluses had a distinctive internal structure consisting of an intricate network of retained trabecular bone. CONCLUSIONS: The timing of a single systemic dose of ZA plays an important role in the modulation of callus properties in this rat fracture model; delaying the single dose produces a larger and stronger callus. 相似文献
64.
Debbie M. Popovich MSN RN CPNP Allison McAlhany MSN RN CPNP 《Newborn and Infant Nursing Reviews》2004,4(1):51
Chlamydia trachomatis is the most prevalent sexually transmitted microbial infection in the United States. The CDC estimates that 3 million people are infected annually, with approximately 50% of infected men and 75% of infected women having few or no recognized symptoms. C. trachomatis is frequently transferred from mother to infant, and the maternal-infant transfer of this disease may have negative consequences for the newborn, such as prematurity, pneumonia, and conjunctivitis. Ocular prophylaxis with silver nitrate and or antibiotics is ineffective in preventing neonatal chlamydial conjunctivitis. By increasing awareness of the potential adverse consequences, initiating screening and treatment of pregnant women, and advocating for newborn assessment and treatment, nurses can enhance the quality of care for mothers and their infants. 相似文献
65.
D Craig Willcox Bradley J Willcox Sanae Shimajiri Sayuri Kurechi Makoto Suzuki 《The American journal of geriatric psychiatry》2007,15(3):252-256
OBJECTIVE: This study retrospectively explored the late-life functional status of Okinawan centenarians. METHODS: Activities of daily living were measured retrospectively at five time points (10, 5, 3, and 1 year prior and present) for 22 centenarians in relation to seven physical, two sensory, and two cognitive functions using the Inoue Index. RESULTS: In all, 82% of individuals were still functioning independently at a mean age of 92 years and almost two-thirds were still functioning independently at a mean age of 97 years. CONCLUSION: Preliminary analyses suggest high functional status in Okinawan centenarians throughout their 90 s. The genetic and environmental factors contributing to this successful aging phenomenon deserve further investigation. 相似文献
66.
67.
Aim: To examine the evidence of benefit in initiating immediate chemotherapy in patients with newly diagnosed asymptomatic metastatic incurable cancer, compared with delaying chemotherapy until symptomatic progression. Methods: Through an extensive review of published reports, we examined the biological, clinical, psychological and ethical background of the issue and reported on the available clinical trial evidence in a variety of tumor types. Results: Only a limited number of clinical trials have directly examined the role of immediate versus delayed chemotherapy in patients with incurable asymptomatic metastatic cancer. Small studies in mesothelioma, colorectal cancer, breast cancer, myeloma, and low‐grade lymphoma suggest no survival benefit for the immediate initiation of chemotherapy. However, there was no evidence in other tumor types. Conclusion: The appropriate timing of chemotherapy initiation in an asymptomatic patient with metastatic cancer remains a substantial question in oncology. Many factors are likely to impact on the decision. However, little if any evidence demonstrates a clear advantage in the immediate initiation of chemotherapy in this setting. 相似文献
68.
69.
Jean-Pierre Chanoine MD PhD Sarah Hampl MD FAAP Craig Jensen MD Mark Boldrin MS Jonathan Hauptman MD 李呈亿 《美国医学会杂志》2006,25(1):34-43
背景:儿童和青少年超重和肥胖正迅速增加。在该人群,单纯行为疗法减肥及维持体重下降的效果有限,但是对药物治疗尚未进行广泛的研究。
目的:确定奥利州他(Orlistat)在青少年体重治疗方面的效果及其安个性。
设计、地点和病例:于美国和加拿大32个中心、539例肥胖青少年(12—16岁;体重指数[body mass index,BMI]在第95百分化之上≥2单位)进行的多ln0、54剧(2000年8月至2002年10月)随机双盲研究。
干预:给予奥利司他(n=357)或安慰剂(n=182)120mg,每口3次,持续1年;加适度低热卡饮食(脂肪占30%)、运动和行为治疗。
主要观察指标:BMI变化;二级指标包括腰围和髋用、体重下降、脂质测量以及机体对口服葡萄糖的血糖和胰岛素反心。
结果:至12周时,两组BMI均有下降;此后,奥利司他组体重维持稳定而安慰剂组则超过基线。研究结束时,奥利司他组BMI下降0.55。而安慰剂组则增加0.31(P=0.001)。与安慰剂组的15.7%相比,奥利司他组26.5%的病例BMI下降≥5%(P=0.005);BMI下降≥10%者分别为4.5%和13.3%(P=0.002)。在研究结束时,奥利司他组体重增加0.53kg,安慰剂组增加3.14kg(P〈0.001)。双能X线吸收测量娃示,这种差异可用脂肪体再的变化解释。奥利司他组腰围下降,安慰剂组腰围上升(-1.33cm比+0.12cm;P〈0.05)。奥利司他组发生轻至中度胃肠道不良事件者为9%-50%,安慰剂组为1%~13%。
结论:与安慰剂比较,奥利司他与饮食、运动和行为改善联合可显著改善肥胖青少年体重的治疗。在这个青少年人群,连续使用奥利司他1年并无重要安全问题,尽管奥利司他组胃肠道不良事件较为常见。 相似文献
70.